Sibannac, Inc. (SNNC) financial statements (2021 and earlier)

Company profile

Business Address 2122 E. HIGHLAND AVENUE, SUITE 425
PHOENIX, AZ 85016
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

8/31/2016
8/31/2015
8/31/2014
8/31/2013
8/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments92746341
Cash and cash equivalents92746341
Receivables 1   
Inventory, net of allowances, customer advances and progress billings   20118
Inventory   20118
Other undisclosed current assets   2211
Total current assets:92756346130
Noncurrent Assets
Property, plant and equipment   2641
Intangible assets, net (including goodwill)11940 
Intangible assets, net (excluding goodwill)11940   
Other undisclosed noncurrent assets 250 13010
Total noncurrent assets:119290 15651
Other undisclosed assets195    
TOTAL ASSETS:32356563202181
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:192372240 
Accounts payable19    
Employee-related liabilities 22  
Interest and dividends payable 20   
Other undisclosed accounts payable and accrued liabilities  70240 
Debt 234   
Disposal group, including discontinued operation346    
Total current liabilities:36625772240 
Noncurrent Liabilities
Liabilities, other than long-term debt250250   
Accounts payable and accrued liabilities 250   
Disposal group, including discontinued operation, liabilities250    
Total noncurrent liabilities:250250   
Other undisclosed liabilities  65413464
Total liabilities:616507138653464
Stockholders' equity
Stockholders' equity attributable to parent, including:(293)58(75)(451)(284)
Common stock1818255
Common stock, value, subscriptions  63
Additional paid in capital4141791131131
Accumulated deficit(351) (868)(587)(420)
Other undisclosed stockholders' equity attributable to parent  (63)  
Total stockholders' equity:(293)58(75)(451)(284)
TOTAL LIABILITIES AND EQUITY:32356563202181

Income statement (P&L) ($ in thousands)

8/31/2016
8/31/2015
8/31/2014
8/31/2013
8/31/2012
Revenues   207288
Cost of revenue
(Cost of Goods and Services Sold)
   (170)(196)
Other undisclosed gross profit   147135
Gross profit:   184227
Operating expenses(133)(2,375)(70)(329)(449)
Other undisclosed operating income 2,241   
Operating loss:(133)(133)(70)(145)(221)
Interest and debt expense   (22)13
Loss from continuing operations:(133)(133)(70)(168)(208)
Income (loss) from discontinued operations(218)657(211)  
Income (loss) before gain (loss) on sale of properties:(351)524(281)(168)(208)
Other undisclosed net loss (2,899)   
Net loss:(351)(2,375)(281)(168)(208)
Other undisclosed net income (loss) attributable to parent 0  (26)
Net loss available to common stockholders, diluted:(351)(2,374)(281)(168)(234)

Comprehensive Income ($ in thousands)

8/31/2016
8/31/2015
8/31/2014
8/31/2013
8/31/2012
Net loss:(351)(2,375)(281)(168)(208)
Comprehensive loss, net of tax, attributable to parent:(351)(2,375)(281)(168)(208)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: